TEVA PHARMACEUTICAL INDUSTRIES LTD - 8-K Filing
Teva raises 2026 outlook for AUSTEDO, AJOVY, and UZEDY following 33% growth in key innovative brands despite a 2% decline in total Q3 revenue. (Items: 2.02 Results of Operations and Financial Condition, 9.01 Financial Statements and Exhibits)
Tickers: $TEVA